Literature DB >> 16168932

Prion diseases.

Richard T Johnson1.   

Abstract

Prion diseases are degenerative disorders of the nervous system caused by transmissible particles that contain a pathogenic isoform of the prion protein, a normal constituent of cell membranes. The most common human prion disease is Creutzfeldt-Jakob disease (CJD). Most cases are sporadic with unknown mode of transmission, 10-15% of cases are inherited, and a small number have been transmitted by medical procedures. The spread of human prion diseases through consumption of infected material has been implicated historically in kuru and recently in variant CJD. Animal prion diseases (scrapie of sheep, transmissible mink encephalopathy, chronic wasting disease of cervids, and bovine spongiform encephalopathy) all seem to be laterally transmitted by contact with infected animals or by consumption of infected feed. The different modes of transmission of different prion diseases, the unpredictable species barriers, the variable distribution of infectivity in tissues, and strain variations found in some diseases all make risk assessment and predictions of future events difficult.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168932     DOI: 10.1016/S1474-4422(05)70192-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  46 in total

Review 1.  Techniques to elucidate the conformation of prions.

Authors:  Martin L Daus
Journal:  World J Biol Chem       Date:  2015-08-26

2.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

3.  Familial Creutzfeldt-Jakob disease with E200K mutation presenting with neurosensorial hypoacusis.

Authors:  R Reñé; J Campdelacreu; I Ferrer; A Escrig; M Povedano; J Gascón-Bayarri; E Moral
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

Review 4.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

5.  Corticobasal syndrome-like variant of Creutzfeldt-Jakob disease: clinical description of two cases.

Authors:  Valentina Arnao; Massimo Gangitano; Fabio Giacalone; Marianna Riolo; Giovanni Savettieri; Paolo Aridon
Journal:  Neurol Sci       Date:  2014-12-17       Impact factor: 3.307

Review 6.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

7.  Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.

Authors:  Özlem Taşkapilioğlu; Meral Seferoğlu; Şükran Yurtoğullari; Bahattin Hakyemez; Sevda Erer; Necdet Karli; Mustafa Bakar; Ö Faruk Turan; Mehmet Zarifoğlu; Şahsine Tolunay; İbrahim Bora
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

8.  Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain.

Authors:  Martin P Boland; Claire R Hatty; Frances Separovic; Andrew F Hill; Deborah J Tew; Kevin J Barnham; Cathryn L Haigh; Michael James; Colin L Masters; Steven J Collins
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

Review 9.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

10.  Progressive Stroke-Like Symptoms in a Patient with Sporadic Creutzfeldt-Jakob Disease.

Authors:  Jukka Lyytinen; Tiina Sairanen; Leena Valanne; Tapani Salmi; Anders Paetau; Eero Pekkonen
Journal:  Case Rep Neurol       Date:  2010-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.